1'-((2'-Methoxy-[1,1'-biphenyl]-3-yl)sulfonyl)-4-methyl-1,4'-bipiperidine

ID: ALA4524927

PubChem CID: 141659837

Max Phase: Preclinical

Molecular Formula: C24H32N2O3S

Molecular Weight: 428.60

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccccc1-c1cccc(S(=O)(=O)N2CCC(N3CCC(C)CC3)CC2)c1

Standard InChI:  InChI=1S/C24H32N2O3S/c1-19-10-14-25(15-11-19)21-12-16-26(17-13-21)30(27,28)22-7-5-6-20(18-22)23-8-3-4-9-24(23)29-2/h3-9,18-19,21H,10-17H2,1-2H3

Standard InChI Key:  JINLMKKTEBXMCB-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   17.0496   -7.4620    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.7595   -7.8706    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   17.7584   -7.0515    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.8066   -7.1814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9894   -7.1773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5795   -7.8790    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.9822   -8.5894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7994   -8.5935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2139   -7.8873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0267   -7.8888    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.4315   -8.5998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2451   -8.6047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6601   -7.9004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2553   -7.1894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4355   -7.1827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3492   -8.5788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5334   -8.5684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1203   -9.2726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5244   -9.9839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3458   -9.9866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7552   -9.2817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4772   -7.9064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3045   -9.2677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9015   -8.5556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0851   -8.5496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6708   -9.2550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0788   -9.9679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8939   -9.9704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2995  -10.6798    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.8880  -11.3858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  4  9  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
 10 11  1  0
 10 15  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
  9 10  1  0
  6  2  1  0
  2 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 13 22  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 18 23  1  0
 28 29  1  0
 29 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4524927

    ---

Associated Targets(Human)

DLD-1 (17511 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 428.60Molecular Weight (Monoisotopic): 428.2134AlogP: 4.25#Rotatable Bonds: 5
Polar Surface Area: 49.85Molecular Species: BASEHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.88CX LogP: 3.68CX LogD: 2.19
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.71Np Likeness Score: -1.26

References

1. Wang W, Zhang L, Morlock L, Williams NS, Shay JW, De Brabander JK..  (2019)  Design and Synthesis of TASIN Analogues Specifically Targeting Colorectal Cancer Cell Lines with Mutant Adenomatous Polyposis Coli (APC).,  62  (10): [PMID:31070915] [10.1021/acs.jmedchem.9b00532]

Source